Vous avez cherché: kratkotrajnim (Croate - Anglais)

koncentracije opijata s kratkotrajnim djelovanjem se mogu povećati.
short-acting opiate concentrations may increase.

Čini dijalog kratkotrajnim za prozor kojeg je odredio 'winid'
makes the dialog transient for the window specified by winid

u kratkotrajnim ispitivanima nije bilo sustavne korelacije odgovora s obzirom na dozu.
in the short-term studies there was no consistent dose-response correlation observed.

izdržljiv , projektiran , trajan -- oni su u suprotnosti s idiosinkrazijskim , krhkim i kratkotrajnim .
durable , engineered , permanent -- those are in opposition to idiosyncratic , delicate and ephemeral .

opijati s kratkotrajnim djelovanjem (alfentanil, fentanil) (supstrat za cyp3a4/5)
short-acting opiates (alfentanyl, fentanyl) (cyp3a4/5 substrate)

ees će omogućiti učinkovito upravljanje odobrenim kratkotrajnim boravcima, povećanu automatizaciju graničnih kontrola te poboljšati otkrivanje prijevara povezanih s ispravama i identitetom.
the ees will allow for the effective management of authorised short-stays, increased automation at border-controls, and improved detection of document and identity fraud.

u bolesnika s nekompliciranom hipertenzijom liječenom rasilamlom u kratkotrajnim kontroliranim ispitivanjima incidencija hipotenzije bila je niska (0,2%).
in patients with uncomplicated hypertension treated with rasilamlo in short-term controlled trials, the incidence of hypotension was low (0.2%).

sigurnosni profil pri dugotrajnijem praćenju u nekontroliranim ispitivanjima (prosjek praćenja 79 tjedana) bio je sličan onom opaženom u kratkotrajnim ispitivanjima.
with longer observation in uncontrolled studies (mean observation of 79 weeks), the safety profile was similar to that observed in the short term studies.

opijati s kratkotrajnim djelovanjem (alfentanil, fentanil): potrebno je paţljivo praćenje radi mogućeg razvoja toksičnosti lijeka i po potrebi smanjenje doze.
short-acting opiates (alfentanyl, fentanyl): careful monitoring for any occurrence of drug toxicity, and dose reduction if required.

budući da je izvor problema zakonodavni jaz između schengenske pravne stečevine o kratkotrajnim boravcima na schengenskom prostoru i zakonodavstva o prihvatu državljana trećih zemalja za boravke dulje od 90 dana na državnom području države članice, neregulatorno rješenje u okviru dotične politike nije razvijeno.
since the problem is due to a legislative gap between the schengen acquis on short stays in the schengen area and the legislation on admission of third-country nationals for stays longer than 90 days on the territory of a member state, a non-regulatory policy option was not developed.

sljedeća tablica sažima nuspojave zabilježene s većom učestalosti u adolescentnih bolesnika (u dobi od 13 do 17 godina) u odnosu na odrasle bolesnike ili nuspojave identificirane samo u kratkotrajnim kliničkim ispitivanjima u adolescentnih bolesnika.
the following table summarises the adverse reactions reported with a greater frequency in adolescent patients (aged 13-17 years) than in adult patients or adverse reactions only identified during short- term clinical trials in adolescent patients.

ekstrapiramidni simptomi (eps): u kratkotrajnim placebo kontroliranim ispitivanjima, incidencija prijavljenih događaja povezanih s eps, ne ubrajajući akatiziju i nemir, bila je 13,5% u ispitanika liječenih lurasidonom, naspram 5,8% onih liječenih placebom.
extrapyramidal symptoms (eps): in the short-term placebo controlled studies, the incidence of reported events related to eps, excluding akathisia and restlessness, was 13.5% for lurasidone-treated subjects versus 5.8% for placebo-treated subjects.